20
Participants
Start Date
December 31, 2008
Primary Completion Date
December 31, 2013
Study Completion Date
December 31, 2013
Zolpidem CR
After a 48-hour period of baseline actigraphy and clinical measurements, study subjects were randomized to take either Zolpidem CR 6.25mg by mouth (1 pink tablet) or Placebo by mouth (also 1 pink tablet) for up to 3 weeks or the end of the subjects' hospital stay.
Placebo
After a 48-hour period of baseline actigraphy and clinical measurements, study subjects were randomized to take either Zolpidem CR 6.25mg by mouth (1 pink tablet) or Placebo by mouth (also 1 pink tablet) for up to 3 weeks or the end of the subjects' hospital stay.
Massachusetts General Hospital, Boston
Collaborators (1)
Sanofi
INDUSTRY
Massachusetts General Hospital
OTHER